AU2017900565A0 - Composition and method of treatment - Google Patents

Composition and method of treatment

Info

Publication number
AU2017900565A0
AU2017900565A0 AU2017900565A AU2017900565A AU2017900565A0 AU 2017900565 A0 AU2017900565 A0 AU 2017900565A0 AU 2017900565 A AU2017900565 A AU 2017900565A AU 2017900565 A AU2017900565 A AU 2017900565A AU 2017900565 A0 AU2017900565 A0 AU 2017900565A0
Authority
AU
Australia
Prior art keywords
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017900565A
Inventor
Layton MILLS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cannpal Pty Ltd
Original Assignee
Cannpal Pty Ltd
Filing date
Publication date
Application filed by Cannpal Pty Ltd filed Critical Cannpal Pty Ltd
Publication of AU2017900565A0 publication Critical patent/AU2017900565A0/en
Abandoned legal-status Critical Current

Links

AU2017900565A 2017-02-21 Composition and method of treatment Abandoned AU2017900565A0 (en)

Publications (1)

Publication Number Publication Date
AU2017900565A0 true AU2017900565A0 (en) 2017-03-09

Family

ID=

Similar Documents

Publication Publication Date Title
EP3664796A4 (en) Terpene-enriched cannabinoid composition and method of treatment
EP3454945A4 (en) Ash1l inhibitors and methods of treatment therewith
EP3694390A4 (en) Endoscope and method of use
EP3681479A4 (en) Method of administration and treatment
EP3426250A4 (en) Methods of treatment
EP3341391A4 (en) Compositions and methods for treatment of pain
EP3585817A4 (en) Compositions and methods for treatment of cancer
EP3706737A4 (en) Ash1l inhibitors and methods of treatment therewith
EP3684342A4 (en) Method of treatment
EP3471763A4 (en) Tuberculosis compositions and methods of treating or preventing tuberculosis
EP3713583A4 (en) Methods and compositions for treatment of skin
EP3429584A4 (en) Compositions and methods for the treatment of presbyopia
EP3554310A4 (en) Packaged skin treatment composition and method
EP3341006A4 (en) Compositions and methods for the treatment of neurodamage
EP3691748A4 (en) Acetaminophen-pregabalin combinations and methods of treating pain
EP3654964A4 (en) Composition and methods for the treatment of myopia
EP3258908A4 (en) Compositions and methods for treatment of skin infections
EP3600285A4 (en) Topical compositions and methods of treatment
EP3694517A4 (en) Compositions and methods for treatment of fibrosis
EP3600329A4 (en) Compositions and method of treating cancer
EP3525787A4 (en) Methods of treatment and pharmaceutical compositions using bcn057 or bcn512
GB201605127D0 (en) Composition and methods of treatment
EP3706767A4 (en) Compositions and methods for the treatment of allergy
EP3645000A4 (en) Method of treatment and dosage forms thereof
EP3727376A4 (en) Methods of treatment of hypertrigl yceridemia